Form 8-K - Current report:
SEC Accession No. 0001140361-25-000337
Filing Date
2025-01-06
Accepted
2025-01-06 16:01:19
Documents
15
Period of Report
2024-12-31
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20040800_8k.htm   iXBRL 8-K 37874
2 EXHIBIT 99.1 ef20040800_ex99-1.htm EX-99.1 14591
6 image00001.jpg GRAPHIC 1919
  Complete submission text file 0001140361-25-000337.txt   202525

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snti-20241231.xsd EX-101.SCH 3983
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snti-20241231_lab.xml EX-101.LAB 22691
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snti-20241231_pre.xml EX-101.PRE 16553
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20040800_8k_htm.xml XML 4398
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 25510970
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)